BHCM
NARI

Brevan Howard Capital Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Brevan Howard Capital Management’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,388
Closed -$1.55M – 1545
2024
Q4 		$1.55M Buy
30,388
+20,861
+219% +$1.03M 0.01% 331
2024
Q3 		$393K Buy
+9,527
New +$457K ﹤0.01% 760

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Brevan Howard Capital Management's NARI Position: Q1 2025 in Review

Brevan Howard Capital Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 30,388 shares — an estimated $1.55M sold.

Brevan Howard Capital Management first reported a position in NARI in Q3 2024 and held it in 2 quarters. The position peaked at $1.55M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Brevan Howard Capital Management reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Brevan Howard Capital Management sold 30,388 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $1.55M.
  • Brevan Howard Capital Management first reported a position in Inari Medical, Inc. Common Stock in Q3 2024 and held it in 2 quarters.
  • Brevan Howard Capital Management's Inari Medical, Inc. Common Stock position peaked at $1.55M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Brevan Howard Capital Management's 13F filing for Q1 2025, filed 15 May 2025.